Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
Tóm tắt
Freund's adjuvants are irreplaceable components of induction protocols of many experimental animal models of autoimmune disease. Apart from the early studies done in the 1950s and 1960s, no further direct investigation on the mode of action of these adjuvants has been undertaken. It is generally assumed that incomplete (IFA) and complete Freund's adjuvant (CFA) act by prolonging the lifetime of injected autoantigen, by stimulating its effective delivery to the immune system and by providing a complex set of signals to the innate compartment of the immune system, resulting in altered leukocyte proliferation and differentiation. Here, we review evidence collected from various types of studies that provide more insight in the specific alterations of the immune response caused by IFA and CFA. Early events include rapid uptake of adjuvant components by dendritic cells, enhanced phagocytosis, secretion of cytokines by mononuclear phagocytes, and transient activation and proliferation of CD4+ lymphocytes. The mycobacterial components within CFA signal T lymphocytes to assume a Th1 profile so that strong delayed-type hypersensitivity against autoantigens develops. In the absence of mycobacteria, T-lymphocyte differentiation tends to assume a Th2 profile with strong antibody production only. The mycobacterial component also accounts for a morphologic and functional remodeling of the haemopoietic system that develops over a period of several weeks and that is characterized by a drastic expansion of Mac-1+ immature myeloid cells. These cells have been found to be associated with enhanced disease in some models but with reduced disease in others. Thus, in experimental autoimmune diseases, CFA-mediated activation of the innate immune compartment is important not only by regulating the early induction phase but also by providing a surplus of effector and regulator cells in the late phase.
Từ khóa
Tài liệu tham khảo
Freund, 1956, The mode of action of immunologic adjuvants, Adv. Tuberc. Res., 7, 130
Lewis, 1924, Allergic irritability, The formation of anti-sheep hemolytic amboceptor in the normal and tuberculous guinea pig. J. Exp. Med., 40, 503
Dienes, 1929, The technic of producing tuberculin type of sensitization with eggwhite in tuberculous guinea pigs, J. Immunol., 17, 531, 10.4049/jimmunol.17.6.531
Rivers, 1933, Observations on attempts to produce acute disseminated encephalomyelitis in monkeys, J. Exp. Med., 58, 39, 10.1084/jem.58.1.39
Freund, 1947, Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion, J. Exp. Med., 57, 179
White, 1967, Role of adjuvants in the production of delayed hypersensitivity, Br. Med. Bull., 23, 39, 10.1093/oxfordjournals.bmb.a070514
Trentham, 1977, Autoimmunity to type II collagen: an experimental model of arthritis, J. Exp. Med., 145, 857, 10.1084/jem.146.3.857
Courtenay, 1980, Immunisation against heterologous type II collagen induces arthritis in mice, Nature, 283, 666, 10.1038/283666a0
Matthys, 1999, Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J, Immunol., 163, 3503, 10.4049/jimmunol.163.6.3503
Joe, 1999, Animal models of rheumatoid arthritis, Mol. Med. Today, 5, 367, 10.1016/S1357-4310(99)01528-2
Holmdahl, 1992, Vaccination and genetic experiments demonstrate that adjuvant-oil-induced arthritis and homologous type II collagen-induced arthritis in the same rat strain are different diseases. Clin. Exp, Immunol., 88, 96
Zhang, 1999, The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats, Immunology, 98, 267, 10.1046/j.1365-2567.1999.00854.x
Carlson, 2000, The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats, Am. J. Pathol., 156, 2057, 10.1016/S0002-9440(10)65077-8
Stasiuk, 1997, Pristane-induced arthritis is CD4+ T cell-dependent, Immunology, 90, 81, 10.1046/j.1365-2567.1997.00121.x
Pearson, 1956, Development of arthritis, periarthritis and periostitis in rats given adjuvants, Proc. Soc. Exp. Biol. Med., 91, 95, 10.3181/00379727-91-22179
Jacobson, 1999, A new spin on an old model: in vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parameters and histopathology in the adjuvant arthritic rat, Arthritis Rheum., 42, 2060, 10.1002/1529-0131(199910)42:10<2060::AID-ANR6>3.0.CO;2-L
Svelander, 1997, Polyclonal T cells transfer oil-induced arthritis, Immunology, 91, 260, 10.1046/j.1365-2567.1997.00251.x
van Eeden, 1998, Do heat shock proteins control the balance of T-cell regulation in inflammatory diseasesarticle-title, Immunol. Today, 19, 303, 10.1016/S0167-5699(98)01283-3
Ratkay, 1993, Complete Freund's adjuvant induces an earlier and more severe arthritis in Mrl-lpr mice, J. Immunol., 151, 5081, 10.4049/jimmunol.151.9.5081
Anonymous, 1988, NIH intramural recommendations for the research use of complete Freund's adjuvant, ILAR News, 9
Canadian Council on Animal Care, 1989, CCAC guidelines on acceptable immunological procedures, SCAW Newsletter, 11, 1
Stills, 1991, The use of Freund's complete adjuvant, Lab. Anim., 20, 25
Rigdon, 1972, Bacteriological and pathological study of animals given Freund adjuvant, Appl. Microbiol., 24, 634, 10.1128/am.24.4.634-637.1972
Wanstrup, 1965, Granulomatous lesions in mice produced by Freund's adjuvant, Acta Path. Microbiol. Scand., 63, 340, 10.1111/apm.1965.63.3.340
Steiner, 1960, The local and systemic effects of Freund's adjuvant and its fractions, A.M.A. Arch. Pathol., 70, 424
Neta, 1979, Adjuvants in the induction of suppressor cells, Infect. Immun., 23, 360, 10.1128/iai.23.2.360-365.1979
Richard, 1987, Suppressor T cells for delayed-type hypersensitivity in susceptible mice infected with Mycobacterium lepraemurium, Int. J. Lepr. Other. Mycobact. Dis., 55, 63
Richard, 1990, Biological properties of factors secreted by antigen-reactive suppressor cells in mice infected with Mycobacterium lepraemurium, Infect. Immun., 58, 3531, 10.1128/iai.58.11.3531-3536.1990
Gosselin, 1995, Cellular target of in vitro-induced suppressor cells derived from the spleen of Mycobacterium lepraemurium-infected mice and role of IFN-γ in their development. J. Leukoc, Biol., 57, 122
Lemieux, 1990, Early accumulation of suppressor cell precursors in the spleen of Mycobacterium lepraemurium-infected mice and analysis of their in vitro-induced maturation, Clin. Exp. Immunol., 81, 116, 10.1111/j.1365-2249.1990.tb05300.x
Toder, 1990, Nonspecific immunopotentiators and pregnancy loss: complete Freund adjuvant reverses high fetal resorption rate in CBA × DBA/2 mouse combination, Am. J. Reprod. Immunol., 24, 63, 10.1111/j.1600-0897.1990.tb01040.x
Toder, 1991, Mouse model for the treatment of immune pregnancy loss, Am. J. Reprod. Immunol., 26, 42, 10.1111/j.1600-0897.1991.tb00701.x
Strassburger, 1992, Immune features in complete Freund adjuvant-treated CBA/J mouse model, Am. J. Reprod. Immunol., 28, 277, 10.1111/j.1600-0897.1992.tb00814.x
McInerney, 1991, Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice, Diabetes, 40, 715, 10.2337/diab.40.6.715
Yagi, 1991, Possible mechanisms of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice. Cell, Immunol., 138, 130
Baxter, 1994, Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity, Scand. J. Immunol., 39, 602, 10.1111/j.1365-3083.1994.tb03419.x
Castro, 1993, Adjuvant treatment increases the resistance to Mycobacterium avium infection of mycobacteria-susceptible mice, Clin. Exp. Immunol., 92, 466, 10.1111/j.1365-2249.1993.tb03422.x
Mussener, 1995, TNF-a dominates cytokine mRNA expression in lymphoid tissues of rats developing collagen- and oil-induced arthritis, Scand. J. Immunol., 42, 128, 10.1111/j.1365-3083.1995.tb03635.x
Rabchevsky, 1999, Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis, Brain Res., 832, 84, 10.1016/S0006-8993(99)01479-1
Di Gianni, 1996, Anti-oxidants inhibit the enhancement of the immune response caused by oil adjuvants, Scand. J. Immunol., 43, 413, 10.1046/j.1365-3083.1996.d01-59.x
Galelli, 1983, Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation, Infect. Immun., 42, 1081, 10.1128/iai.42.3.1081-1085.1983
Yarkoni, 1979, Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6, 6′-dimycolate (cord factor), Infect. Immun., 24, 571, 10.1128/iai.24.2.571-572.1979
Roach, 1993, Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes of c-fos, KC, JE, and tumor necrosis factor-α. J, Immunol., 150, 1886, 10.4049/jimmunol.150.5.1886
Chatterjee, 1998, Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects, Glycobiology, 8, 113, 10.1093/glycob/8.2.113
Golenbock, 2001, Extolling the diversity of bacterial endotoxins, Nature Immunol., 2, 286, 10.1038/86289
Zhang, 1993, Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components, J. Clin. Investig., 91, 2076, 10.1172/JCI116430
Barnes, 1992, Cytokine production by Mycobacterium tuberculosis lipoarabinomannan, J. Immunol., 149, 541, 10.4049/jimmunol.149.2.541
Vouret-Craviari, 1997, Expression of monocyte chemotactic protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan, Cytokine, 9, 992, 10.1006/cyto.1997.0242
Yamagami, 2001, Trehalose 6, 6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensivity-type granulomas in mice, Infect. Immun., 69, 810, 10.1128/IAI.69.2.810-815.2001
Kol, 2000, Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells, J. Immunol., 164, 13, 10.4049/jimmunol.164.1.13
Ohashi, 2000, Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J. Immunol., 164, 558, 10.4049/jimmunol.164.2.558
Weiner, 2000, The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides, J. Leukoc. Biol., 68, 455, 10.1189/jlb.68.4.455
Chu, 1997, CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity, J. Exp. Med., 186, 1623, 10.1084/jem.186.10.1623
Sparwasser, 1999, Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis, J. Immunol., 162, 2368, 10.4049/jimmunol.162.4.2368
Dresser, 1960, Elimination of 131I-labelled protein antigens from the circulation of the mouse, Immunology, 3, 289
Dresser, 1961, Effectiveness of lipid and lipidophilic substances as adjuvants, Nature, 191, 1169, 10.1038/1911169a0
van der Heyden, 1986, Separate application of adjuvant and antigen: the effect of water-in-oil emulsion on the splenic plaque-forming cell response to sheep red blood cells in mice, Immunobiology, 171, 143, 10.1016/S0171-2985(86)80023-7
Herbert, 1968, The mode of action of mineral-oil emulsion adjuvants on antibody production in mice, Immunology, 14, 301
Tsuji, 2000, Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: involvement of Toll-like receptors, Infect. Immun., 68, 6883, 10.1128/IAI.68.12.6883-6890.2000
Pulendran, 2001, Sensing pathogens and tuning immune responses, Science, 293, 253, 10.1126/science.1062060
Nicol, 1966, Stimulation of phagocytosis in relation to the mechanism of action of adjuvants, Nature, 209, 1142, 10.1038/2091142b0
Mitchell, 1965, Ultrastructure of the antigen-retaining reticulum of lymph node follicles as shown by high-resolution autoradiography, Nature, 208, 500, 10.1038/208500b0
Lind, 1968, Cellular localization of 125I-labelled Salmonella adelaide flagellin following injection into the rat in the presence of Freund's complete adjuvant. Aust. J. Exp. Biol. Med, Sci., 46, 189
Lamoureux, 1968, Lymph node localization and whole body distribution of radioiodinated encephalitogenic polypeptide in guinea-pigs, Clin. Exp. Immunol., 3, 25
McDevitt, 1966, The localization of antigen in relation to specific antibody-producing cells, 1. Use of a synthetic polypeptide [(T, G,)-A—L] labelled with iodine-125. Immunology, 11, 337
Kleinau, 1995, Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane, Int. J. Immunopharmacol., 17, 393, 10.1016/0192-0561(95)00020-3
Dupuis, 1998, Dendritic cells internalize vaccine adjuvant after intramuscular injection, Cell. Immunol., 186, 18, 10.1006/cimm.1998.1283
Yip, 1999, Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response, J. Immunol., 162, 3942, 10.4049/jimmunol.162.7.3942
Heeger, 2000, Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant, J. Immunol., 164, 5771, 10.4049/jimmunol.164.11.5771
Stasiuk, 1996, Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with Type II collagen, Cell. Immunol., 173, 269, 10.1006/cimm.1996.0277
Appelberg, 1994, Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection, Infect. Immun., 62, 3962, 10.1128/iai.62.9.3962-3971.1994
Harshan, 1991, In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice, Infect. Immun., 59, 2818, 10.1128/iai.59.8.2818-2821.1991
Orme, 1992, Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retrovirus. Infect, Immun., 60, 4747
Sugisaki, 1998, Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions, J. Leukoc. Biol., 63, 440, 10.1002/jlb.63.4.440
Flesch, 1995, Early interleukin-12 production by macrophages in response to mycobacterial infections depends on interferon γ and tumor necrosis factor, J. Exp. Med., 181, 1615, 10.1084/jem.181.5.1615
Cooper, 1995, The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection, Immunology, 84, 423
Castro, 1995, Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice, J. Immunol., 155, 2013, 10.4049/jimmunol.155.4.2013
Wakeham, 1998, Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J, Immunol., 160, 6101, 10.4049/jimmunol.160.12.6101
Cooper, 1997, Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis, J. Exp. Med., 186, 39, 10.1084/jem.186.1.39
Wang, 1999, Macrophages are a significant source of type 1 cytokines during mycobacterial infection, J. Clin. Investig., 103, 1023, 10.1172/JCI6224
Huygen, 1991, Interleukin-6 production in Mycobacterium bovis BCG-infected mice, Cell. Immunol., 137, 224, 10.1016/0008-8749(91)90071-I
Champsi, 1995, Production of TNF-α, IL-6 and TGF-β, and expression of receptors for TNF-α, and IL-6, during murine Mycobacterium avium infection, Immunology, 84, 549
VanHeyningen, 1997, IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses, J. Immunol., 158, 330, 10.4049/jimmunol.158.1.330
Sanceau, 1990, Secretion of interleukin 6 by human monocytes stimulated by muramyl dipeptide and tumor necrosis factor alpha, Immunology, 69, 52
Zhang, 1994, Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-6 and NF-κB Proc, Natl. Acad. Sci. USA, 91, 2225, 10.1073/pnas.91.6.2225
Cerwenka, 2001, Ligands for natural killer cell receptors: redundancy or specificity, Immunol. Rev., 181, 158, 10.1034/j.1600-065X.2001.1810113.x
Matthys, 2000, The protective effect of IFN-γ in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis, J. Leukoc. Biol., 68, 447, 10.1189/jlb.68.4.447
Lin, 1998, Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis, Infect. Immun., 66, 1121, 10.1128/IAI.66.3.1121-1126.1998
Chensue, 1997, Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks, J. Immunol., 159, 3565, 10.4049/jimmunol.159.7.3565
Zhang, 1995, Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components, J. Clin. Investig., 95, 586, 10.1172/JCI117702
Kamijo, 1993, Mice that lack the interferon-γ receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp, Med., 178, 1435
Flynn, 1993, An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection, J. Exp. Med., 178, 2249, 10.1084/jem.178.6.2249
Sugawara, 1998, Induction of granulomas in interferon-γ gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis, J. Med. Microbiol., 47, 871, 10.1099/00222615-47-10-871
Kindler, 1989, The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection, Cell, 56, 731, 10.1016/0092-8674(89)90676-4
Senaldi, 1996, Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J, Immunol., 157, 5022, 10.4049/jimmunol.157.11.5022
Chu, 2000, Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp, Med., 192, 123
Dalton, 2000, Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells, J. Exp. Med., 192, 117, 10.1084/jem.192.1.117
Hickey, 1991, Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation, Brain Pathol., 1, 97, 10.1111/j.1750-3639.1991.tb00646.x
Hickey, 1991, T-lymphocyte entry into the central nervous system, J. Neurol. Sci. Res., 28, 254
Wekerle, 1994, Contra: evidence against a primary lesion in the target organ in autoimmune diesease, Int. Arch. Allergy Immunol., 103, 328, 10.1159/000236650
Buhles, 1978, Increased bone marrow production of granulocytes and mononuclear phagocytes induced by mycobacterial adjuvants: improved recovery of leukopoiesis in mice after cyclophos-phamide treatment. Infect, Immun., 20, 58
Vincent-Naulleau, 1997, Stimulatory effects of polar glycopeptidolipids of Mycobacterium chelonae on murine haematopoietic stem cells and megakaryocyte progenitors, Res. Immunol., 148, 127, 10.1016/S0923-2494(97)82484-4
Madonna, 1989, Trehalose dimycolate enhances resistance to infection in neutropenic animals, Infect. Immun., 57, 2495, 10.1128/iai.57.8.2495-2501.1989
Murray, 1998, Hematopoietic remodelling in interferon-γ-deficient mice infected with mycobacteria, Blood, 91, 2914, 10.1182/blood.V91.8.2914.2914_2914_2924
Hayashida, 1992, Bone marrow changes in adjuvant-induced and collagen-induced arthritis, Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis. Arthritis Rheum., 35, 241